Stratification of gliomas according to the latest WHO 2021 classification revealed elevated SMAD9 mRNA levels in IDH-wildtype glioblastoma compared to both IDH-mutant astrocytomas and oligodendrogliomas (Fig. 2b). Here, SMAD9 is linked to central nervous system cancer.